Karo Pharma set to acquire E45 brand from Reckitt

24 December 2021 - Deborah Wilkes

Premium

Sweden’s Karo Pharma is set to acquire the E45 dermatology brand from Reckitt in a deal worth GBP200 million (USD268 million).

Click tags below for more information on topics:

Karo Pharma Reckitt

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: